Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|15|13|1205-1214
ISSN: 1389-4501
Source: Current Drug Targets, Vol.15, Iss.13, 2014-12, pp. : 1205-1214
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Immune Therapy of Multiple Sclerosis - Future Strategies
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :
Interferon- Therapy in Multiple Sclerosis: Evidence for a Clinically Relevant Dose Response
By Goodin D.S.
Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. :
Medical Lipid-Regulating Therapy: Current Evidence, Ongoing Trials and Future Developments
By Evans M.
Drugs, Vol. 64, Iss. 11, 2004-01 ,pp. :
Advances in Antioxidative Therapy of Multiple Sclerosis
Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. :